UDR | ||
|---|---|---|
OUTLOOK RATING 1..100 | 65 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 84 Overvalued | |
PROFIT vs RISK RATING 1..100 | 82 | |
SMR RATING 1..100 | 85 | |
PRICE GROWTH RATING 1..100 | 56 | |
P/E GROWTH RATING 1..100 | 76 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ICF | UDR | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 82% | N/A |
| Stochastic ODDS (%) | 1 day ago 82% | 1 day ago 53% |
| Momentum ODDS (%) | 1 day ago 85% | 1 day ago 52% |
| MACD ODDS (%) | 1 day ago 85% | 1 day ago 45% |
| TrendWeek ODDS (%) | 1 day ago 80% | 1 day ago 53% |
| TrendMonth ODDS (%) | 1 day ago 82% | 1 day ago 57% |
| Advances ODDS (%) | 6 days ago 86% | 6 days ago 52% |
| Declines ODDS (%) | N/A | 1 day ago 52% |
| BollingerBands ODDS (%) | 1 day ago 79% | 1 day ago 43% |
| Aroon ODDS (%) | 1 day ago 79% | 1 day ago 44% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBC | 42.20 | 0.28 | +0.67% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||
| DFSI | 44.91 | 0.13 | +0.29% |
| Dimensional International Sstby Cr 1 ETF | |||
| XTRE | 49.61 | 0.01 | +0.01% |
| BondBloxx Bloomberg ThreeYrTrgDurUSTrETF | |||
| JFLI | 52.15 | -0.02 | -0.05% |
| JPMorgan Flexible Income ETF | |||
| BGM | 2.39 | -0.55 | -18.71% |
| Qilian International Holding Group Ltd | |||
A.I.dvisor indicates that over the last year, ICF has been closely correlated with EQR. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if ICF jumps, then EQR could also see price increases.
A.I.dvisor indicates that over the last year, UDR has been closely correlated with CPT. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if UDR jumps, then CPT could also see price increases.